Reuse What’s Accepted. Rebuild Only What’s Needed.

Challenge

A medical device already had overseas regulatory approvals and supporting conformity-assessment evidence. Treating Australia as a completely new dossier could have duplicated work, cost and launch time.

Our Strategy

We first assessed whether the existing overseas evidence could support the Australian pathway, including alignment of the device design, intended purpose and indications. We then separated reusable evidence from Australia-specific requirements and built the ARTG strategy around the actual gaps.

How It Helped

Instead of recreating an established evidence package, the manufacturer could leverage appropriate existing documentation and focus effort only where Australian requirements required something additional.

Impact

Less duplication. Faster regulatory preparation. A more efficient pathway toward ARTG inclusion.

NKB Insight

Global evidence has value when you know what Australia accepts—and how to use it correctly.

*Client, device, overseas approval and Australian Sponsor details have been intentionally anonymized to protect confidentiality.